LITS - רווח נקי למניה (EPS TTM) Lite Strategy Inc

Lite Strategy Inc generates revenue by developing targeted cancer therapies while adhering to basic environmental standards through digital management. This chart of the moving average net income per share, presented on GURU.Markets, shows that -1.39 is hitting a new level. The holding company's success depends on the results of clinical trials for oncology drugs and its ability to attract investment for their registration.

The investment attractiveness of Lite Strategy Inc (LITS) is determined by the business's ability to generate stable earnings per share. This metric is calculated as the ratio of total annual net income to the total number of shares outstanding. By analyzing the TTM annual earnings per share, an investor assesses the actual efficiency of capital allocation. The company's centralized outsourcing of operational processes directly impacts the dynamics of this value. The upward trend confirms the resilience of the business model and the growth in asset value.